By using www.3bfuturehealth.com website you agree to our use of cookies to enhance your experience.
We have updated our Terms of Use, Privacy & Cookies Policies in October 2022. To review them please follow the links below
Terms of Use | Privacy and Cookies Policy
8 August 2016
Helsinn Group and MEI Pharma Enter Strategic Agreement for the Development and Commercialization of Pracinostat for the Treatment of Acute Myeloid Leukemia and Other Hematologic Diseases
Thank you for your form submission, we will get in contact with you shortly.